Loading

JSM Foot and Ankle

The Efficacy of Prophylactic Single Dose Intravenous Antibiotics vs. Multi Dose Intravenous or Oral Antibiotics in Elective Foot and Ankle Surgery

Research Article | Open Access | Volume 1 | Issue 3

  • 1. Department of Orthopedic Surgery, Tel Aviv University, Israel
+ Show More - Show Less
Corresponding Authors
Dror Robinson, Department of Orthopedic Surgery, Tel Aviv University, 7 Keren Kayemet Str. Petah Tikwa, Israel, Tel: 972-3-9372233; Fax: 972-8-9206013
Abstract

A prospective evaluation of wound healing of 675 patients who underwent elective foot and ankle surgeries between 2011 and 2015 at a single hospital clinic was performed to evaluate the effect of two prophylactic antibiotic regimens. Only those patients who were having elective foot or ankle surgery and were being followed up at the hospital’s outpatient clinic, patients had a traumatic or non-traumatic cause for their surgery. The ASEPSIS classification system was used to define wound healing with a grade of more than 20 considered an infection. Two hundred and twenty patients (32.6%) patients received a single dose preoperative antibiotic and 455 (67.4%) patients received a prolonged prophylactic treatment. Of the 455 patients who received a prolonged antibiotic treatment, 444 had unimpaired healing (97.8%), 3 had impaired healing and the rest (8 patients, 1.5%) had postoperative infections. Among the single dose antibiotic group, 181 (82.7%) had normal healing, 24 (10.9%) had impaired healing and 15 (6.8%) had an infection. The intergroup difference was significant (ANOVA, p<0.001). The results suggest that prophylactic intravenous antibiotic use combined with post-operative treatment in routine elective foot and ankle surgery might be expected to reduce the complication rates and impaired wound healing.

Keywords

•    Prophylactic antibiotics
•    Foot and ankle surgery
•    Wound infections
•    Impaired wound healing

Citation

Yassin M, Garti A, Heller E, Robinson D (2016) The Efficacy of Prophylactic Single Dose Intravenous Antibiotics vs. Multi Dose Intravenous/ Oral Antibiotics in Elective Foot and Ankle Surgery. JSM Foot Ankle 1(3): 1017.

INTRODUCTION

There is a controversy regarding the appropriateness of single dose pre-operative antibiotics in foot and ankle surgery though it is well documented that skin preparation does not eliminate surgical site bacteria in most elective foot operations [1]. More than 70 percent of patients have a positive culture at the hallux following skin preparation, and even at the ankle more than 15 percent is contaminated after skin preparation [1]. Some studies indicate that preoperative antibiotics have a positive effect on the prevention of postoperative wound infections in certain high risk foot procedures [2], while other studies failed to indicate an advantage for antibiotic prophylaxis [3]. Especially in diabetic patients the organisms tend to be resistant to cefalosporins, perhaps explaining some of the increased infection risk in that group. A recent task force of the American College of Foot and Ankle Surgeons stopped short of clear cut recommendations regarding antibiotic prophylaxis in elective foot surgery [4], though suggesting that antibiotic prophylaxis routine prophylaxis will likely be continued at most institutions, because few complications have been reported with the practice.

Although the incidence of postoperative wound infection is low in elective orthopaedic surgery, if an infection does occur, the final outcome can lead to unfortunate consequences. The incidence of infection rate in clean orthopaedic surgery is between 0.5% to 9.2% [5,6], depending on the author and procedure. Apparently the higher range of infection rates occur in foot surgery possibly due to operative site contamination that appears to be very common in foot surgery [1].

A drawback of antibiotic prophylaxis might be the generation of highly antibiotic resistant bacteria and thus routine antibiotic surgery in low infection risk patients has been questioned [7,8]. However most foot surgeries are not low-risk as a large proportion of patients are diabetic, elderly or with some degree of circulatory deficiency. In addition, there is a significant risk of contamination by multi-drug-resistant bacteria of surgical scrubs [7] that might indicate a risk of contamination by the medical team rather than bactermia that appears to be rare in foot surgery [9] (Figure 1).

Figure 1 The percentage of patients acquiring a wound infection by type of  antibiotic regimen used. Note the percentage of patients having impaired  wound healing or having an infection was significantly higher in the single  dose preoperative antibiotic group than in the prolonged multi dose antibiotic  treatment group

Figure 1: The percentage of patients acquiring a wound infection by type of antibiotic regimen used. Note the percentage of patients having impaired wound healing or having an infection was significantly higher in the single dose preoperative antibiotic group than in the prolonged multi dose antibiotic treatment group

MATERIALS AND METHODS

A prospective wound evaluation of 675 patients receiving elective foot and ankle surgeries 2011 and 2015 at a single hospital clinic was performed to evaluate the effect of two prophylactic antibiotic regimens by one of the authors (D.R.). All patients had a preoperative evaluation by one of the foot and ankle surgeons (n = 2) at the outpatient clinic of the hospital. The evaluation consisted of a history and physical examination, preoperative foot radiographs, and laboratory studies when indicated. All surgeries were performed by the both surgeons who performed the preoperative evaluation.

GROUP DESIGNATION

The series represents a sequential series of patients operated by both surgeons and followed up in the hospital outpatient clinic. Up to May 2013 patients were treated by single dose preoperative antibiotics. From May 2013 onward, due to a change in departmental policy due to an impression of a high wound complication rate, a multi-dose antibiotic treatment regimen was used. Patients were excluded from the series if they had a prior history of open wounds, infection, or open fractures of the foot or ankle. All patients were followed up postoperatively at the hospital’s outpatient clinic by one of the authors. Postoperative care included physical examination, wound inspection, foot radiographs on a routine basis with laboratory work-up reserved for cases of postoperative infection and/or complications (Figure 2).

Figure 2 Distribution of ASEPSIS wound score by type of antibiotic regimen  used. It appears that the major groups that are improved by the prolonged  antibiotic treatment regimen are the impaired wound healing group as well as  the moderate to severe infection groups.

Figure 2: Distribution of ASEPSIS wound score by type of antibiotic regimen used. It appears that the major groups that are improved by the prolonged antibiotic treatment regimen are the impaired wound healing group as well as the moderate to severe infection groups.

CLASSIFICATION OF OPERATIVE PROCEDURE

It was assumed that closed and endoscopic surgery might be associated with less infection risk, and that longer hindfoot procedures might carry a higher risk of infection than forefoot surgeries. Thus, the 675 charts were divided into several surgical categories to include forefoot surgery with implants and without implants as well as percutaneous forefoot surgery. Mid foot surgery either open or closed and hindfoot surgery again divided between closed percutaneous approaches and open surgeries. A last category was endoscopic surgery at all foot regions. Patients who had more than 1 procedure performed at the time of their surgery (eg, first metatarsal osteotomy and correction of hammertoes) were assigned according to the procedure that was of the presumed higher risk category. Both groups had similar proportion of endoscopic cases (about 20%). The multi-dose group had a higher percentage of high risk procedures (open hind-foot 21%) than the single dose group (11%, Wilcoxon-Rank test, p<0.03).

DATA EXTRACTION

From the patient charts, the following data were extracted: prophylactic antibiotic use, age, gender, presence of diabetes (defined as either fasting blood glucose higher than 125 mg/dl or an A1C level of 6.5 percent or higher), and use of implants. Additionally, the ASEPSIS wound healing score [10] was available for analysis.

SURGICAL TECHNIQUE AND FOLLOW-UP PROCEDURE

All patients undergoing foot and ankle surgeries were scrubbed and draped in the same manner according to the hospital’s policy. Skin preparation included scrubbing twice with chlorhexidine gluconate (Septal Scrub, Teva Medical Ltd, Israel), drying with a sterile towel, and painting twice with Chlordhexidine Alcohol solution (Chlorhexidine gluconate 0.5%W/, Isopropanolol 70% V/V, Teva Medical Ltd, Israel). Preoperative prophylactic intravenous antibiotics were administered 30-60 minutes before skin-cut for all patients. Cefazolin sodium 1 gram (Cefamezin 1 gram, Teva Medical Ltd. Israel) was administered for all patients without a known allergy to penicillin. In 67 patients with previous history of penicillin allergy, clindamicin 300 mg IV (Dalacin-C, Teva Medical Ltd., Israel) was administered. Post- operative treatment depended on time of discharge and known penicillin allergies. According to department policy, patients were discharged if they were discharged from recovery at 13:00 or earlier, Patients operated later in the day were hospitalized overnight. Routine post-operative treatment included intravenous cefazolin sodium 1 gram (Cefamezin 1 gram, Teva Medical Ltd. Israel), every eight hours for 24 hours for patients hospitalized overnight (128 patients) followed by amoxicillin trihydrate 875 mg / potasium clavulanic acid 125 mg (Smithkline Beecham Plc, UK) twice a day for one week. Patients who were same-day discharged were treated by oral augmenting alone. Penicillin-allergic patients were treated by oral clindamycin 600 mg twice a day for one week.

Postoperative follow-up was performed at the outpatient clinic at one week post operative, two weeks post operative and six weeks postoperative. The ASEPSIS score was graded at every visit and the worse score recorded was used in the current analysis.

DATA ANALYSIS

The data obtained from the clinical follow-up and chart reviews of each patient were grouped according to whether or not single dose preoperative antibiotics were administered or a combination of preoperative antibiotics and postoperative treatment. Descriptive statistics consisting of means and standard deviations for the quantitative data were then obtained.

Frequencies for the categorical data were calculated for each of the study groups. t tests were conducted to determine if any differences existed between the 2 study groups with respect to their mean age, gender or the presence of diabetes. Additionally, chi-square tests of association were performed to determine if the antibiotic regimen used was associated with any of the study factors (gender, metal fixation use, surgical category, and presence of diabetes). All statistical testing was conducted by using the Analyze-it software package (version 2.30, Excel 12+).

RESULTS

A total of 675 charts were reviewed; Two hundred and twenty patients (32.6%) patients received a single dose preoperative antibiotic until a change in departmental policy took place. Since then455 (67.4%) patients received a prolonged multi dose prophylactic treatment (Table 1).

Table 1: Patient Demographics.

Parameter

Single Pre-Operative Dose

Multiple Post-Operative Treatment

Number of Subjects

220

455

Females

131 (39.6%)

275 (60.4%)

Males

89 (40.4%)

180 (59.5%)

Age Average ±SD (Range)

41±19 (18-92)

44±22 (18-89)

Diabetes

65 (29.5%)

141 (31%)

Procedure Classification

Forefoot Percutaneous

20 (9%)

67 (15%)

Forefoot With Implants

66 (30%)

107 (24%)

Forefoot Open No Implants

46 (21%)

46 (10%)

Mid Foot Open

11 (5%)

24 (5%)

Mid Foot Closed

0

12 (3%)

Hindfoot Open

24 (11%)

95 (21%)

Hindfoot Closed

7 (3%)

21 (5%)

Arthroscopic

46 (21%)

83 (18%)

The distribution of the type of the procedures was not similar in both groups (Kruskal-Wallis test, chi-square 5.68, p<0.02) with more open forefoot procedures without implants in the single antibiotic group and more open hindfoot procedures in the multiple antibiotic group (Table 1).

Administration of single dose antibiotic was associated with higher impaired healing rates in patients with implants as well as in patients without implants as compared to multiple dose antibiotic treatement (Kruskal-Wallis’ statistic 108.8, p<0.001).

ASEPSIS score was significantly higher in the single dose preoperative antibiotics group (5.4 ± 9.2) versus the multiple dose antibiotic treatment groups (0.83 ± 3.7).

Of the 455 patients who received a prolonged antibiotic treatment, 444 had unimpaired healing (97.8%), 3 had impaired healing and the rest (8 patients, 1.5%) had postoperative infections. Among the single dose antibiotic group, 181 (82.7%) had normal healing, 24 (10.9%) had impaired healing and 15 (6.8%) had an infection (Table 2).

Table 2: Healing of Surgical Incisions by Type of Antibiotic Treatment.

Healing Grading

ASEPSIS Score

Single Pre-Operative Dose (%)

Multiple Post-Operative Treatment (%)

satisfactory healing

0-10

181 (82.3%)

444 (97.6%)

impaired healing

11-20

24 (10.9%)

3   (0.6%)

mild wound infection

21-30

6   (2.7%)

8   (1.7%)

moderate wound infection

31-40

6   (2.7%)

0      (0%)

severe wound infection

>40

3   (1.3%)

0      (0%)

Total

 

220 (100%)

455 (100%)

 

The overall intergroup difference was significant (ANOVA, p<0.001). Most intergroup difference was in the impaired healing group.

Preoperative single dose antibiotic use was associated (P <0.01) with postoperative impaired wound healing and infection in a post-hoc analysis of the entire cohort. Overall, diabetic patients had higher ASEPSIS scores (3.7 ± 9) than non-diabetic patients (1.7 ± 4.7) and the difference was significant (ANOVA, F=14.5, p<0.001). Diabetic patients in the single antibiotic dose group had a significantly worse ASEPSIS score (8.4 ± 12.6) than non-diabetic patients (4.2 ± 6.9, ANOVA, F-Statistic 37.7, p<0.001), but ASEPSIS scores were similar in the multiple antibiotic dose group (Table 3).

Table 3: The effect on antibiotic regimen on the ASEPSIS score by presence of diabetes.

ASEPSIS SCORE by diabetes and antibiotics

Number of Cases

Mean ± SD

single & no diabetes

155

4.2±6.9

single & diabetes

65

8.4±12.8

multiple & no diabetes

314

0.5±2.7

multiple & diabetes

141

1.6±5.3

Source of variation

Sum squares

DF

Mean square

F statistic

p

Diabetes And Antibiotics

4041.2

3

1347.1

37.68

<0.0001

Single & No Diabetes V Single & Diabetes

-4.2

-6.5

to -1.9

(significant)

 

Single & No Diabetes V Multiple & No Diabetes

3.7

2.2

to 5.2

(significant)

 

Single & No Diabetes V Multiple & Diabetes

2.6

0.8

to 4.4

(significant)

 

Single & Diabetes V Multiple & No Diabetes

7.9

5.8

to 10.0

(significant)

 

Single &Diabetes V Multiple &Diabetes

6.8

4.5

to 9.1

(significant)

 

Multiple & No Diabetes V Multiple & Diabetes

-1.1

-2.7

to 0.5

   

 

Use of implants was not associated with increased rates of impaired wound healing (2.0 ± 6.1) as compared to operations without implants use (2.3 ± 6.7, ANOVA F-statistic 1.82, p>0.17). ASEPSIS score correlation to other factors was calculated. There was a negative correlation (r=-0.33) with the antibiotic regimen, as well as arthroscopic and closed procedures (r=-0.22), and positively correlated with the presence of diabetes (r=0.15)

A total of 14/675 patients required formal wound revision in an operative room setting. 3/455 in the multiple dose group versus 11/220 in the single dose group (the difference is significant with p<0.001 Wilcoxon-Mann-Whitney test). The odds ratio of the need for revision in the multiple antibiotic dose group compared with the standardly used single dose was 0.12 with the Miettinen-Nurminen 95% Confidence Interval at 0.037-0.47). Multivariate analysis was employed to assess the possible interaction effect of the need for wound revision with the presence of diabetes, antibiotic treatment and the presence of implants. Pearson’s r was calculated using Fisher’s z method at the 90% confidence interval level. The only significant factor appeared to be the presence of implants and the type to antibiotic treatment (r=0.07, p<0.05).

 

DISCUSSION

Surgical infection is an important and deleterious complication of foot and ankle surgery. It is particularly common in cases of implant removal where a up to ten percent infection rate can be expected [11]. The high frequency of surgical site infections (SSI) combined with the large number of foot and ankle procedures performed creates a major healthcare and financial burden. Unfortunately limited data is available regarding optimal strategies of decreasing SSI’s in foot and ankle surgery. The optimal surgical preoperative cleaning regimen is not well defined and there is only weak evidence that the type of surgical scrub and anti-sepsis solution used affects surgical infection rates [12]. The importance of pre-operative antibiotics in foot and ankle surgery is not well established either, and there is some controversy regarding optimal prophylactic agent choice [13]. The study results seem to indicate that the type of antibiotic prophylaxis affects the frequency of impaired wound healing and infection in clean foot and ankle surgery. In our specific institute the rate of diabetes mellitus is high, a disease that has been associated with almost doubling of complication rates [14]. Due to high infection rate, a new concept was developed, assuming that the foot and ankle surgical case is clean-contaminated and treating with a full antibiotic course instead of prophylactic treatment as is commonly use. This study is unique in the approach of treating the supposedly clean surgical patient as potentially infected and treating the patient pre-incision and for a week after operation. The concept is due to the relatively high frequency of infection and impaired wound healing in clean foot surgery [5]. Following anti-septic surgical field preparation the majority of toes are still colonized by potentially pathogenic bacteria [1]..

Traditionally, studies investigating antibiotic prophylaxis in foot and ankle surgery compared frequency of infection between groups with and without antibiotic prophylaxis [15] and failed to show a clear cut advantage. Other studies have not shown an advantage of one antibiotic over the other [16]. However these studies have not used the ASEPSIS score [10] as an endpoint. The advantage of this score is that it is sensitive enough to define a group with impaired wound healing and allows diagnosis of three times as many clinically infected wounds as evaluations based on the presence of pus alone [17]. In additions the ASEPSIS score appears to correlate quite well with the definitions of the Center for Disease Control [18]. A few studies have looked at multi dose versus single dose treatment especially in trauma settings and seem to indicate that a single dose is equivalent to multi dose therapy in open tibial fractures [19]. The population treated in the current study is very different than the one treated by the open tibial fracture study. The definition of infection in the Patzak is study was presence of fever, erythema, wound discharge and positive wound culture [19]. This definition would exclude many cases of impaired wound healing as defined by the ASEPSIS criteria and tend to underestimate the frequency of impaired wound healing. On the one hand the risk of infection is apparently higher as in this group of open tibia fractures, the patients were younger (average age 33 years in the cephalosporin group). Another major difference in the treated population of the current study is the high prevalence of diabetes at our institute, while the Patzak is study does not mention the frequency of diabetes in their population, the prevalence in the current study population is very high and the advantage of the multidose therapy appears to be in reducing the rate of impaired wound healing subjects with ASEPSIS scores of 10 to 20 and reducing the excess risk of infection in diabetic patients. Thus, it is possible that the results in open tibial fractures do not reflect the optimal treatment regimen in elective foot and ankle surgery.

In order to define the potential clinical significance of reduction in the number of these impaired wound healing cases, an analysis of the need for wound revision was carried out. Confirming the preliminary study hypothesis, multi-dose antibiotic therapy was found to decrease the number of formal wound revisions. This finding might tip the balance in favor of multi dose antibiotic treatment as this might offset the increased cost of secondary surgery.

The current study has the advantage of being a consecutive series of cases performed by a single surgical team using the same techniques. As in any single center study, there is a legitimate concern whether the results can be generalized to other localities and centers. Another disadvantage of the current study is the lack of randomization. While RCT remain the gold-standard of clinical trials, their cost is quite prohibitive. Also there is a definite advantage to a ‘real world’ consecutive series of patients, as compared to the bias often introduced by sophisticated inclusion\exclusion criteria, making generalization to the general population difficult.

In conclusion, it appears reasonable to conclude that due to the high risk of skin contamination in foot and ankle surgery even after surgical skin preparation reported to vary between 20-75% depending on exact protocol, the surgery should be considered clean-contaminated and wound healing and infection rates can be reduced by prophylactic administration of a one week long multi dose antibiotic treatment.

REFERENCES

1. Ostrander RV, Brage ME, Botte MJ. Bacterial skin contamination after surgical preparation in foot and ankle surgery. Clin Orthop Relat Res. 2003: 246-252.

2. Rusmir A, Salerno A. Postoperative infection after excisional toenail matrixectomy: a retrospective clinical audit. J Am Podiatr Med Assoc. 2011; 101: 316-322.

3. Paiement GD, Renaud E, Dagenais G, Gosselin RA. Double-blind randomized prospective study of the efficacy of antibiotic prophylaxis for open reduction and internal fixation of closed ankle fractures. J Orthop Trauma. 1994; 8: 64-66.

4. Dayton P, DeVries JG, Landsman A, Meyr A, Schweinberger M. American college of foot and ankle surgeons’ clinical consensus statement: perioperative prophylactic antibiotic use in clean elective foot surgery. J Foot Ankle Surg. 2015; 54: 273-279. 

5. Schepers T, Van Lieshout EM, de Vries MR, Van der Elst M. Complications of syndesmotic screw removal. Foot Ankle Int. 2011; 32: 1040-1044.

6. Jones RN, Wojeski WV. Single-dose cephalosporin prophylaxis of 929 surgical procedures in a prepaid group practice: a prospective, randomized comparison of cefoperazone and cefotaxime. Diagn Microbiol Infect Dis. 1987; 6: 323-334.

7. Xu SG, Mao ZG, Liu BS, Zhu HH, Pan HL. Evaluating the use of antibiotic prophylaxis during open reduction and internal fixation surgery in patients at low risk of surgical site infection. Injury. 2015; 46: 184- 188.

8. Krueger CA, Murray CK, Mende K, Guymon CH, Gerlinger TL. The bacterial contamination of surgical scrubs. Am J Orthop (Belle Mead NJ). 2012; 41: E69-73.

9. Trepal MJ, Brunetti V, Hodge WR. Intraoperative bacteremia during foot surgery. J Foot Surg. 1988; 27: 47-51.

10. Wilson AP, Weavill C, Burridge J, Kelsey MC. The use of the wound scoring method ‘ASEPSIS’ in postoperative wound surveillance. J Hosp Infect. 1990; 16: 297-309.

11. Backes M, Schep NW, Luitse JS, Goslings JC, Schepers T. Indications for implant removal following intra-articular calcaneal fractures and subsequent complications. Foot Ankle Int. 2013; 34: 1521-1525.

12. Dumville JC, McFarlane E, Edwards P, Lipp A, Holmes A. Preoperative skin antiseptics for preventing surgical wound infections after clean surgery. Cochrane Database Syst Rev. 2013: CD003949.

13. Tucker A, Henderson L, Moffatt R, Abela R, Troughton J, McMullan R, et al. Antibiotic Prophylaxis Regimens in Trauma and Orthopaedic Surgery: Are We Providing Adequate Cover Against Colonizing Organisms? Foot Ankle Spec. 2016; 9: 351-353.

14. Schipper ON, Jiang JJ, Chen L, Koh J, Toolan BC. Effect of diabetes mellitus on perioperative complications and hospital outcomes after ankle arthrodesis and total ankle arthroplasty. Foot Ankle Int. 2015; 36: 258-267.

15. Zgonis T, Jolly GP, Garbalosa JC. The efficacy of prophylactic intravenous antibiotics in elective foot and ankle surgery. J Foot Ankle Surg. 2004; 43: 97-103.

16. Periti P, Jacchia E. Ceftriaxone as short-term antimicrobial chemoprophylaxis in orthopedic surgery: a 1-year multicenter follow-up. Preliminary results of a controlled multicentre study. Eur Surg Res. 1989; 21: 25-32.

17. Chiew YF, Theis JC. Comparison of infection rate using different methods of assessment for surveillance of total hip replacement surgical site infections. ANZ J Surg. 2007; 77: 535-539.

18. Henriksen NA, Meyhoff CS, Wetterslev J, Wille-Jørgensen P, Rasmussen LS, Jorgensen LN. PROXI Trial Group. Clinical relevance of surgical site infection as defined by the criteria of the Centers for Disease Control and Prevention. J Hosp Infect. 2010; 75: 173-177.

19. Patzakis MJ, Harvey JP, Ivler D. The role of antibiotics in the management of open fractures. J Bone Joint Surg Am. 1974; 56: 532- 541

Yassin M, Garti A, Heller E, Robinson D (2016) The Efficacy of Prophylactic Single Dose Intravenous Antibiotics vs. Multi Dose Intravenous/ Oral Antibiotics in Elective Foot and Ankle Surgery. JSM Foot Ankle 1(3): 1017.

Received : 10 Aug 2016
Accepted : 15 Dec 2016
Published : 20 Dec 2016
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X